gadolinium dtpa has been researched along with gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate in 94 studies
Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) |
---|---|---|---|---|---|
12,654 | 664 | 4,051 | 638 | 31 | 243 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (13.83) | 18.7374 |
1990's | 36 (38.30) | 18.2507 |
2000's | 12 (12.77) | 29.6817 |
2010's | 29 (30.85) | 24.3611 |
2020's | 4 (4.26) | 2.80 |
Authors | Studies |
---|---|
Brown, RD; Brucher, E; Geraldes, CF; Koenig, SH; Sherry, AD; Spiller, M | 1 |
Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
Kumar, K; Tweedle, MF; Wedeking, P | 2 |
Doyon, DL; Halimi, PM; Lhuillier, FM; Sigal, RC; Sterkers, JM | 1 |
Ekholm, SE; Morris, TW; Prentice, LI | 1 |
Ekholm, SE; Leakey, P; Marinetti, GV; Morris, TW; Prentice, LI | 1 |
Koenig, SH | 2 |
Paajanen, H | 1 |
Gelblum, DY; Jacobson, S; Runge, VM | 1 |
Doucet, D; Meyer, D; Schaefer, M | 1 |
Gries, H; Press, WR; Weinmann, HJ | 1 |
Ahkong, QF; Fritz, T; Tilcock, C; Unger, E | 1 |
Lex, L | 1 |
Stark, DD; Weissleder, R | 1 |
Adelman, LS; Jacobson, S; Kaufman, DM; Runge, VM; Wood, ML | 1 |
Allard, M; Bonnemain, B; Caillé, JM; Meyer, D; Simonnet, G | 1 |
Allard, M; Bonnemain, B; Caille, JM; Kien, P; Simonnet, G | 1 |
Fischer, H; Maton, F; Muller, RN; Rinck, PA; Roch, A; Vallet, P; Van Haverbeke, Y; Vander Elst, L | 1 |
Amiel, M; Baguet, J; Belleville, J; Corot, C; Eloy, R; Paul, J | 1 |
Allard, M; Bonnemain, B; Caillé, JM; Doucet, D; Kien, P | 1 |
Tweedle, M; Wedeking, P | 1 |
Bousquet, JC; Ferrucci, JT; Hahn, PF; Nigam, M; Saini, S; Stark, DD; Wittenberg, J | 1 |
Bennett, HF; Brasch, RC | 1 |
Belleville, J; Corot, C; Eloy, R; Paul, J | 1 |
Adelman, LS; Jacobson, S; Kaufman, D; Runge, VM; Wood, ML | 1 |
Corot, C; Curtelin, L; Hentsch, AM | 1 |
Derugin, N; Higgins, CB; Lauerma, K; Roberts, TP; Saeed, M; Varadarajan, J; Watson, AD; Wendland, MF; Yu, KK | 1 |
Berry, I; Brugières, P; de Schepper, AM; Degryse, HR; Gaston, A; Le Bras, F; Manelfe, C; Marsault, C; Parizel, PM; Wichmann, W | 1 |
Beaufils, H; Bourbouze, R; Brillet, G; Deray, G; Dubois, M | 1 |
Goudemant, JF; Muller, RN; Van Haverbeke, Y; Vander Elst, L | 1 |
Balériaux, D; De Greef, D; Matos, C | 1 |
Abs, R; Mahler, C; Martin, JJ; Parizel, PM; Van de Kelft, E; Van Marck, E; Verhelst, J; Verlooy, J; Willems, PJ | 1 |
De Schepper, AM; Delaporte, C; Forton, GE; Martin, JJ; Mulkens, TH; Parizel, PM; van de Heyning, PH | 1 |
Debatin, JF; Huch Böni, RA; Krestin, GP | 1 |
Benderbous, S; Clément, O; Cuénod, CA; Frija, G; Siauve, N | 1 |
Kellar, KE; Koenig, SH | 1 |
Nowak, PJ; Oudkerk, M; Sijens, PE; van den Bent, MJ; van Dijk, P | 1 |
Berthommier, C; Bonnemain, B; Corot, C; Goulas, V; Hermine, C; Idée, JM; Santus, R; Schaefer, M | 1 |
Hayashi, N; Kawaguchi, T; Kawamura, J; Kobayashi, S; Nakagawa, T; Sakuma, H; Shiraishi, T; Takeda, K; Tochigi, H; Yanagawa, M | 1 |
Amici, F; Ercolani, P; Valeri, G | 1 |
Aime, S; Gasco, MR; Morel, S; Terreno, E; Ugazio, E | 1 |
Chatal, JF; Curtet, C; Havet, T; Maton, F; Mishra, A; Muller, RN; Slinkin, M | 1 |
Laurent, S; Muller, RN; Vander Elst, L | 1 |
Bendayan, M; Clément, O; Cuénod, CA; Frija, G; Rasio, E; Siauve, N | 1 |
Blay, JY; Bochu, M; Bonmartin, A; Desuzinges, C; Ongolo-Zogo, P; Philip, T; Sau, J; Thiesse, P | 1 |
Baba, Y; Murakami, R; Onomichi, M; Takahashi, M; Yamashita, Y | 1 |
Berthommier, C; Corot, C; Devoldere, L; Diai, A; Idee, JM; Lin, J; Port, M; Raynal, I; Robert, M | 1 |
Kim, JH; Kim, S; Min, BG; Moon, WK | 1 |
Kramann, B; Schneider, G; Seidel, R; Uder, M; Wagner, D; Weinmann, HJ | 1 |
Dedieu, V; Emerit, V; Fau, P; Joffre, F; Otal, P; Renou, JP; Vincensini, D | 1 |
Leach, MO; Murphy, PS; Rowland, IJ | 1 |
Alfieri, G; Biondi, L; Calabi, L; De Miranda, M; Ghelli, S; Paleari, L | 1 |
Born, C; Leinsinger, G; Nagel, B; Reiser, M | 1 |
Beaudouin, E; Blanloeil, Y; Guilloux, L; Kanny, G; Moneret-Vautrin, DA; Renaudin, JM | 1 |
Barra, S; Botta, M; Chan, KW; Wong, WT | 1 |
Allegrini, PR; McSheehy, PM; Rausch, M; Weidensteiner, C | 1 |
Dewey, M; Hamm, B; Kaufels, N; Laule, M; Peukert, D; Taupitz, M | 1 |
Corot, C; Dencausse, A; Idee, JM; Medina, C; Port, M | 1 |
Albert, A; Brauckmann, C; Günsel, A; Karst, U; Krämer, BK; Künnemeyer, J; Nowak, S; Telgmann, L; Terborg, L; Tokmak, F; Wiesmüller, GA | 1 |
Bousquet, PJ; Cavigioli, S; Demoly, P; Galera, C; Pur Ozygit, L | 1 |
Burden, AD; Edward, M; Jardine, AG; Newton, BB; Quinn, JA | 1 |
Agrawal, P; Gabor, F; Körner, W; Lonkai, J; Nicolay, K; Ratzinger, G; Sanders, HM; Strijkers, GJ; Terreno, E; Wirth, M | 1 |
Beissner, RS; Morelli, JN; Runge, VM; Tweedle, M; Williams, JM | 1 |
Alfakih, K; Chiribiri, A; Hussain, S; Ishida, M; Lossnitzer, D; Merkle, N; Morton, G; Nagel, E; Paul, M; Plein, S; Schnackenburg, B; Schuster, A; Steen, H | 1 |
Han, H; Jin, C; Li, K; Li, S; Qiu, D; Shu, C; Wang, C; Yang, Y; Ye, L; Zhen, M; Zheng, J | 1 |
de Blas, A; Esteban-Gómez, D; Helm, L; Platas-Iglesias, C; Rodríguez-Blas, T | 1 |
Allen, JS; Caruthers, SD; Hu, G; Lanza, GM; Schmieder, AH; Wickline, SA; Williams, TA; Winter, PM; Zhang, H | 1 |
Kiessling, F | 1 |
Birka, M; Karst, U; Sperling, M; Telgmann, L; Wehe, CA | 1 |
Caravan, P; Jacques, V; Kolodziej, AF; Overoye-Chan, K; Zhang, Z | 1 |
Aita, K; Amano, Y; Kitamura, M; Kumita, S; Tachi, M; Takayama, M; Yamada, F | 1 |
Baudimont, F; Bourgery, S; Bruneval, P; Corot, C; Factor, C; Fretellier, N; Idée, JM; Jestin-Mayer, G; Luseau, A; Maazouz, M; Mecieb, F; Rasschaert, M | 1 |
Haaga, J; Jin, E; Lu, ZR; Malamas, AS; Zhang, Q | 1 |
Azzi, J; Chen, JW; Hannah Degeling, M; Kuijten, MM; Nicolay, K; Tannous, BA; Waterman, P; Weissleder, R; Wojtkiewicz, G | 1 |
Birka, M; Hachmöller, O; Karst, U; Sperling, M; Wehe, CA | 1 |
Kameo, S; Kartamihardja, AA; Koyama, H; Nakajima, T; Tsushima, Y | 1 |
Dijkstra, H; Kappert, P; Oudkerk, M; Sijens, PE | 1 |
Erdene, K; Kameo, S; Khairinisa, MA; Koibuchi, N; Koyama, H; Lamid-Ochir, O; Nakajima, T; Tsushima, Y; Tumenjargal, A | 1 |
Arheden, H; Borgquist, R; Carlsson, M; Chaudhry, U; Engblom, H; Heiberg, E; Jablonowski, R; van der Pals, J; Wu, KC | 1 |
Arslan-Yildiz, A; Demirçak, N; Türker, E | 1 |
Miller, JH; Pokorney, A; Robison, RK | 1 |
Akyildiz, K; Beyazal Polat, H; Beyazal, M; Celiker, FB; Inecikli, MF; Mercantepe, T; Suzan, ZT; Tumkaya, L; Turan, A; Yilmaz, A | 1 |
Chatterjee, AR; Roberts, DR | 1 |
Baudimont, F; Corot, C; Fretellier, N; Granottier, A; Grindel, AL; Idée, JM; Rasschaert, M; Robert, P | 1 |
Andriana, P; Hanaoka, H; Kameo, S; Kartamihardja, AAP; Koyama, H; Takahashi, A; Tsushima, Y | 1 |
Endrikat, J; Frenzel, T; Jost, G; Noebauer-Huhmann, IM; Pietsch, H; Rohrer, M; Szomolanyi, P; Trattnig, S | 1 |
Hartman, RP; Hunt, CH; Kallmes, DF; Kolbe, AB; Maddox, DE; McDonald, JS; McDonald, RJ; Schmitz, JJ | 1 |
Caravan, P; Erstad, DJ; Fuchs, BC; Gale, EM; Jordan, VC; Ramsay, IA; Sojoodi, M; Tanabe, KK | 1 |
Damm, R; Fischbach, F; Fischbach, K; Gazis, A; Haneder, S; Pech, M; Persigehl, T; Siedek, F; Steinhauser, S; Wenzel, O; Wybranski, C | 1 |
Hasebe, T; Hotta, A; Kurokawa, N; Matsumoto, T; Okamoto, Y; Yano, K | 1 |
Laney, V; Li, Y; Lu, ZR | 1 |
Chen, K; Luo, Y; Xie, L; Xu, L; Yang, X; Yu, C; Zhang, J | 1 |
6 review(s) available for gadolinium dtpa and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Article | Year |
---|---|
Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1990 |
Early experience of paramagnetic tracers in ultra low magnetic fields.
Topics: Animals; Contrast Media; Fibrinogen; Gadolinium DTPA; Heterocyclic Compounds; Immunoglobulin G; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rabbits; Serum Albumin, Bovine; Swine | 1990 |
Development of contrast enhancing agents in magnetic resonance imaging.
Topics: Animals; Antibodies; Contrast Media; Ferric Compounds; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liposomes; Magnetic Resonance Imaging; Nitrogen Oxides; Organometallic Compounds; Pentetic Acid; Porphyrins | 1989 |
Magnetic resonance imaging of liver tumors.
Topics: Adenoma, Bile Duct; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1989 |
Contrast-enhanced MR imaging of the kidneys and adrenal glands.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1996 |
Dynamic MRI of the breast.
Topics: Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity | 1998 |
3 trial(s) available for gadolinium dtpa and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Article | Year |
---|---|
Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).
Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1994 |
Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.
Topics: Brain; Brain Neoplasms; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Spinal Cord; Spinal Cord Neoplasms | 1993 |
3D and 2D delayed-enhancement magnetic resonance imaging for detection of myocardial infarction: preclinical and clinical results.
Topics: Aged; Animals; Chronic Disease; Contrast Media; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Myocardial Infarction; Organometallic Compounds; Predictive Value of Tests; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Swine; Swine, Miniature; Time Factors | 2007 |
85 other study(ies) available for gadolinium dtpa and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Article | Year |
---|---|
Nuclear magnetic relaxation dispersion profiles of aqueous solutions of a series of Gd(NOTA) analogs.
Topics: Aza Compounds; Chelating Agents; Contrast Media; Edetic Acid; Electron Spin Resonance Spectroscopy; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Organometallic Compounds; Organophosphorus Compounds; Pentetic Acid; Structure-Activity Relationship | 1992 |
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |
Dissociation of gadolinium chelates in mice: relationship to chemical characteristics.
Topics: Animals; Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Male; Mice; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1992 |
Magnetic resonance imaging of acoustic neuromas: pitfalls and differential diagnosis.
Topics: Contrast Media; Diagnosis, Differential; Ear, Inner; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Neurofibromatosis 2; Neuroma, Acoustic; Organometallic Compounds; Pentetic Acid | 1992 |
The effects of gadolinium-DTPA and -DOTA on neural tissue metabolism.
Topics: Animals; Carbon Dioxide; Contrast Media; Dose-Response Relationship, Drug; Gadolinium DTPA; Glucose; Heterocyclic Compounds; Hippocampus; In Vitro Techniques; Organometallic Compounds; Pentetic Acid; Rabbits; Rats; Rats, Inbred Strains | 1991 |
Gd-DTPA and Gd-DOTA effects on metabolism of glucose and phosphatidylinositols.
Topics: Animals; Brain; Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Glucose; Heterocyclic Compounds; Hippocampus; In Vitro Techniques; Male; Organometallic Compounds; Pentetic Acid; Phosphatidylinositols; Rats; Rats, Inbred Strains; Synaptosomes | 1991 |
Gd HP-DO3A--experimental evaluation in brain and renal MR.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Image Enhancement; Kidney; Kidney Cortex; Kidney Medulla; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Models, Structural; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Time Factors | 1991 |
Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
Topics: Albumins; Animals; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats | 1990 |
Tolerance of extracellular contrast agents for magnetic resonance imaging.
Topics: Animals; Contrast Media; Drug Combinations; Drug Tolerance; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats | 1990 |
Paramagnetic liposomes as magnetic resonance contrast agents.
Topics: Animals; Drug Carriers; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Male; Mice; Organometallic Compounds; Pentetic Acid; Rats | 1990 |
Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Kidney Medulla; Magnetic Resonance Imaging; Male; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344 | 1989 |
Action of gadolinium complexes on different enzyme systems.
Topics: Animals; Brain; Choline O-Acetyltransferase; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Glutamate Decarboxylase; Heterocyclic Compounds; In Vitro Techniques; Organometallic Compounds; Pentetic Acid; Rats | 1986 |
Brain distribution of MRI contrast media in rats after intracisternal injection.
Topics: Animals; Brain; Cisterna Magna; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1987 |
The importance of nuclear magnetic relaxation dispersion (NMRD) profiles in MRI contrast media development.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1988 |
In vitro interactions of gadolinium DOTA meglumine and gadolinium DTPA meglumine on hemostasis.
Topics: Contrast Media; Gadolinium DTPA; Hemostasis; Heterocyclic Compounds; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1988 |
Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties.
Topics: Animals; Contrast Media; Drug Tolerance; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1988 |
Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
Topics: Acetates; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Male; Mice; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1988 |
Gd-DOTA: characterization of a new paramagnetic complex.
Topics: Animals; Chemical Phenomena; Chemistry; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetics; Mice; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains; Tissue Distribution | 1988 |
Considerations in the choice of contrast media for MR imaging.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1988 |
[In vitro study of the action of DOTA and DTPA-gadolinium complexes on platelet functions: aggregation and calcium excretion].
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Calcium; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; In Vitro Techniques; Male; Organometallic Compounds; Pentetic Acid; Platelet Aggregation | 1988 |
MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
Topics: Animals; Brain Neoplasms; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1988 |
Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Topics: Animals; Calcium; Chelating Agents; Contrast Media; Excipients; Femur; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections, Intravenous; Liver; Male; Mice; Organometallic Compounds; Pentetic Acid; Radioisotopes; Rats; Time Factors; Tissue Distribution | 1995 |
The need for electron paramagnetic resonance and water exchange-rate data for understanding small magnetic resonance imaging contrast agents and their macromolecular complexes.
Topics: Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Macromolecular Substances; Magnetic Resonance Imaging; Magnetics; Organometallic Compounds; Pentetic Acid; Water | 1994 |
Interaction of gadolinium complexes with metal-dependent biological systems.
Topics: Cell Division; Cells, Cultured; Chlorides; Contrast Media; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid; Peptidyl-Dipeptidase A; Zinc Compounds | 1994 |
Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement.
Topics: Albumins; Animals; Body Water; Contrast Media; Dose-Response Relationship, Drug; Echo-Planar Imaging; Female; Gadolinium; Gadolinium DTPA; Half-Life; Heart Ventricles; Heterocyclic Compounds; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Myocardium; Organometallic Compounds; Pentetic Acid; Polylysine; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1994 |
Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diatrizoate; Gadolinium DTPA; Heterocyclic Compounds; Kidney; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
Topics: Contrast Media; Drug Stability; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid | 1994 |
The association of meningioma and pituitary adenoma: report of seven cases and review of the literature.
Topics: Adenoma; Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Growth Hormone; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meninges; Meningioma; Middle Aged; Neoplasms, Multiple Primary; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1993 |
MRI of acoustic schwannoma: a retrospective study of 89 tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroma, Acoustic; Organometallic Compounds; Pentetic Acid; Retrospective Studies | 1993 |
Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications.
Topics: Animals; Capillary Permeability; Contrast Media; Female; Gadolinium DTPA; Heterocyclic Compounds; Liver; Lymph; Macromolecular Substances; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rabbits | 1996 |
Theory of proton relaxation in solutions of magnetic nanoparticles, including the superparamagnetic size range.
Topics: Animals; Contrast Media; Ferrosoferric Oxide; Gadolinium DTPA; Heterocyclic Compounds; Humans; Iron; Magnetic Resonance Imaging; Models, Theoretical; Organometallic Compounds; Oxides; Particle Size; Pentetic Acid | 1996 |
1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.
Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Fourier Analysis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hydrogen; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid; Regression Analysis | 1997 |
Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
Topics: Animals; Blood Pressure; Calcium; Chelating Agents; Contrast Media; Diltiazem; Gadolinium; Gadolinium DTPA; Hemodynamics; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Phentolamine; Rats; Rats, Sprague-Dawley | 1998 |
Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Contrast Media; Cricetinae; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Urinary Bladder; Urinary Bladder Neoplasms | 1998 |
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.
Topics: Contrast Media; Drug Carriers; Emulsions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Lipids; Magnetic Resonance Spectroscopy; Microspheres; Organometallic Compounds | 1998 |
Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to anti-CEA F(ab')2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Electrophoresis, Polyacrylamide Gel; Gadolinium DTPA; Heterocyclic Compounds; Immunoconjugates; Immunoglobulin Fab Fragments; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Organometallic Compounds; Polylysine; Tumor Cells, Cultured | 1998 |
Multinuclear magnetic resonance characterization of paramagnetic contrast agents. The manifold effects of concentration and counterions.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Spectroscopy; Organometallic Compounds | 1998 |
The rete mirabile of the eel: a useful model for the study of transcapillary passage of MR contrast agents.
Topics: Air Sacs; Albumins; Animals; Capillary Permeability; Contrast Media; Dextrans; Eels; Female; Ferrosoferric Oxide; Gadolinium DTPA; Heterocyclic Compounds; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides | 1999 |
Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
Topics: Adolescent; Adult; Bone and Bones; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Osteosarcoma; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 1999 |
Dynamic magnetic resonance imaging of head and neck lesions.
Topics: Algorithms; Contrast Media; Factor Analysis, Statistical; Gadolinium; Gadolinium DTPA; Head and Neck Neoplasms; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds | 1999 |
Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents.
Topics: Bromthymol Blue; Calcium; Colorimetry; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mass Spectrometry; Organometallic Compounds; Pharmaceutical Solutions; Phenolphthaleins; Spectrophotometry, Ultraviolet; Titrimetry | 1999 |
Lesion characterization using vessel permeability map to new blood pool contrast agent calculated from dynamic magnetic resonance images.
Topics: Abscess; Animals; Capillary Permeability; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Neoplasms, Experimental; Organometallic Compounds; Rabbits; Sensitivity and Specificity; Testicular Neoplasms; Tumor Cells, Cultured | 2000 |
In vivo microscopic evaluation of the microvascular behavior of FITC-labeled macromolecular MR contrast agents in the hamster skinfold chamber.
Topics: Animals; Capillary Permeability; Contrast Media; Cricetinae; Extravasation of Diagnostic and Therapeutic Materials; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Melanoma, Amelanotic; Melanoma, Experimental; Microcirculation; Microscopy, Fluorescence; Organometallic Compounds; Random Allocation; Skin Neoplasms; Time Factors; Video Recording | 2000 |
Rapid relaxation times measurements by MRI: an in vivo application to contrast agent modeling for muscle fiber types characterization.
Topics: Animals; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Leg; Magnetic Resonance Spectroscopy; Models, Statistical; Muscle Fibers, Skeletal; Organometallic Compounds; Rabbits | 2000 |
The effects of paramagnetic contrast agents on metabolite protons in aqueous solution.
Topics: Choline; Computer Simulation; Contrast Media; Dose-Response Relationship, Drug; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Organometallic Compounds; Protons; Time Factors; Water | 2002 |
Application of high-resolution magic-angle spinning NMR spectroscopy to define the cell uptake of MRI contrast agents.
Topics: Cell Membrane Permeability; Contrast Media; Erythrocytes; Fourier Analysis; Gadolinium DTPA; Heterocyclic Compounds; Humans; Leukocytes; Magnetic Resonance Spectroscopy; Meglumine; Organometallic Compounds; Tissue Distribution | 2002 |
[MRI with oral filling in patients with chronic inflammatory bowel diseases].
Topics: Administration, Oral; Adult; Artifacts; Biopsy; Colonoscopy; Contrast Media; Crohn Disease; Diuretics, Osmotic; Enema; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Ileitis; Ileum; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Models, Statistical; Organometallic Compounds; Time Factors; Ultrasonography | 2003 |
Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
Topics: Adult; Anaphylaxis; Contrast Media; Cross Reactions; Drug Hypersensitivity; Female; Gadolinium DTPA; Heterocyclic Compounds; Histamine Release; Humans; Intradermal Tests; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2003 |
Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Temperature | 2004 |
Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.
Topics: Animals; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Kinetics; Magnetic Resonance Imaging; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Nude; Models, Statistical; Organometallic Compounds; Phantoms, Imaging; Rats; Time Factors | 2006 |
Stability of gadolinium chelates and their biological consequences: new data and some comments.
Topics: Animals; Contrast Media; Drug Stability; Gadolinium; Gadolinium DTPA; Half-Life; Heterocyclic Compounds; Mice; Organometallic Compounds | 2008 |
Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry.
Topics: Adult; Contrast Media; Electrophoresis, Capillary; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Kinetics; Magnetic Resonance Imaging; Male; Mass Spectrometry; Meglumine; Organometallic Compounds | 2009 |
Gadoteridol-induced anaphylaxis - not a class allergy.
Topics: Aged; Anaphylaxis; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hypersensitivity; Male; Meglumine; Organometallic Compounds; Skin Tests | 2010 |
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
Topics: Adult; Cell Proliferation; Collagen; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hyaluronic Acid; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds | 2010 |
Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents.
Topics: Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Lactic Acid; Magnetic Resonance Imaging; Nanospheres; Organometallic Compounds; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2010 |
Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model.
Topics: Animals; Area Under Curve; Brain Neoplasms; Contrast Media; Disease Models, Animal; Fibrin; Fluorescent Antibody Technique, Direct; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Organometallic Compounds; Rats; Rats, Inbred F344 | 2011 |
Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance.
Topics: Adenosine; Contrast Media; Coronary Artery Disease; Feasibility Studies; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections; Linear Models; Magnetic Resonance Imaging, Cine; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Vasodilator Agents | 2011 |
Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
Topics: Cell Tracking; Contrast Media; Drug Evaluation, Preclinical; Drug Stability; Drug Synergism; Fullerenes; Gadolinium DTPA; HeLa Cells; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Serum Albumin | 2012 |
Hyperfine coupling constants on inner-sphere water molecules of Gd(III)-based MRI contrast agents.
Topics: Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Models, Molecular; Organometallic Compounds; Water | 2012 |
Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
Topics: Analysis of Variance; Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Disease Progression; Gadolinium DTPA; Heterocyclic Compounds; Hindlimb; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Least-Squares Analysis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Neovascularization, Pathologic; Organometallic Compounds; Rabbits; Statistics, Nonparametric | 2013 |
Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging?
Topics: Contrast Media; Disease Progression; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Integrin alphaVbeta3; Magnetic Resonance Imaging; Molecular Imaging; Nanoparticles; Neovascularization, Pathologic; Organometallic Compounds | 2013 |
Sensitive quantification of gadolinium-based magnetic resonance imaging contrast agents in surface waters using hydrophilic interaction liquid chromatography and inductively coupled plasma sector field mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Contrast Media; Fresh Water; Gadolinium DTPA; Germany; Heterocyclic Compounds; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Mass Spectrometry; Organometallic Compounds; Regression Analysis; Water Pollutants, Chemical | 2013 |
Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents.
Topics: Amino Acid Sequence; Collagen; Contrast Media; Fibrin; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Molecular Sequence Data; Organometallic Compounds; Peptides; Staining and Labeling; Structure-Activity Relationship | 2014 |
Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Hypertrophic; Catheter Ablation; Constriction, Pathologic; Contrast Media; Echocardiography; Female; Gadolinium DTPA; Heart Septum; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Organometallic Compounds; Postoperative Complications | 2015 |
Safety profiles of gadolinium chelates in juvenile rats differ according to the risk of dissociation.
Topics: Animals; Contrast Media; Female; Gadolinium DTPA; Heterocyclic Compounds; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Risk; Skin | 2014 |
Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
Topics: Angiogenesis Inhibitors; Animals; Bumetanide; Capillary Permeability; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Cyclohexanes; DEET; Gadolinium DTPA; Heterocyclic Compounds; HT29 Cells; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Mice; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds | 2015 |
Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging.
Topics: Animals; Biotin; Brain Neoplasms; Cell Line, Tumor; Contrast Media; ErbB Receptors; Gadolinium DTPA; Gene Expression; Glioma; Green Fluorescent Proteins; Heterocyclic Compounds; Humans; Injections, Subcutaneous; Lipid Bilayers; Liposomes; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Optical Imaging; Organometallic Compounds; Protein Binding; Rhodamines; Streptavidin; Temperature | 2015 |
Tracing gadolinium-based contrast agents from surface water to drinking water by means of speciation analysis.
Topics: Chemistry Techniques, Analytical; Chromatography, Liquid; Contrast Media; Drinking Water; Environmental Monitoring; Gadolinium DTPA; Germany; Heterocyclic Compounds; Hydrophobic and Hydrophilic Interactions; Mass Spectrometry; Organometallic Compounds; Rivers; Water Pollutants, Chemical | 2016 |
Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
Topics: Animals; Brain; Contrast Media; Disease Models, Animal; Female; Gadolinium DTPA; Heterocyclic Compounds; Mice; Organometallic Compounds; Renal Insufficiency; Spectrophotometry, Atomic | 2016 |
Assessment of the link between quantitative biexponential diffusion-weighted imaging and contrast-enhanced MRI in the liver.
Topics: Adolescent; Adult; Aged; Child; Contrast Media; Diffusion Magnetic Resonance Imaging; Evaluation Studies as Topic; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2017 |
Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents.
Topics: Animals; Animals, Newborn; Blood; Bone and Bones; Brain; Contrast Media; Female; Gadolinium DTPA; Heterocyclic Compounds; Kidney; Liver; Maternal-Fetal Exchange; Mice; Models, Animal; Mothers; Organ Specificity; Organometallic Compounds; Pregnancy; Spectrophotometry, Atomic; Spleen; Tissue Distribution | 2017 |
Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
Topics: Aged; Algorithms; Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Decision Support Techniques; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardium; Organometallic Compounds; Patient Selection; Predictive Value of Tests; Primary Prevention; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Unnecessary Procedures | 2017 |
Scaffold-free three-dimensional cell culturing using magnetic levitation.
Topics: Animals; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Epithelial Cells; Gadolinium DTPA; Gravitation; Heterocyclic Compounds; Humans; Magnetic Fields; Magnets; Mice; NIH 3T3 Cells; Organometallic Compounds; Tissue Engineering | 2018 |
Evaluation of the effect of switching from a linear to a macrocyclic contrast agent on the T
Topics: Astrocytoma; Brain; Brain Neoplasms; Cerebellar Nuclei; Contrast Media; Follow-Up Studies; Gadolinium DTPA; Globus Pallidus; Heterocyclic Compounds; Humans; Linear Models; Magnetic Resonance Imaging; Male; Organometallic Compounds; Retrospective Studies; Rhabdomyosarcoma; Young Adult | 2019 |
Effects of Gadodiamide and Gadoteric Acid on Rat Kidneys: A Comparative Study.
Topics: Animals; Chelating Agents; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Immunohistochemistry; Infusions, Intravenous; Ions; Kidney; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prospective Studies; Rats; Rats, Sprague-Dawley | 2019 |
The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body.
Topics: Animal Experimentation; Animals; Brain; Child; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Organometallic Compounds; Rats | 2019 |
Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
Topics: Age Factors; Aging; Animals; Bone and Bones; Brain; Contrast Media; Disease Models, Animal; Female; Gadolinium DTPA; Heterocyclic Compounds; Male; Microscopy, Fluorescence; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Spectrophotometry, Atomic | 2019 |
Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
Topics: Animals; Brain; Chromatography, Gel; Contrast Media; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Mice; Models, Animal; Organometallic Compounds; Saline Solution | 2019 |
Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 T.
Topics: Blood; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Phantoms, Imaging | 2019 |
Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
Topics: Acute Disease; Adult; Aged; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors | 2019 |
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Topics: Animals; Breast Neoplasms; Contrast Media; Diamines; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Manganese Compounds; Mice; Mice, Inbred BALB C; Organometallic Compounds; Picolinic Acids; Tissue Distribution | 2019 |
Respiratory motion artefacts in Gd-EOB-DTPA (Primovist/Eovist) and Gd-DOTA (Dotarem)-enhanced dynamic phase liver MRI after intensified and standard pre-scan patient preparation: A bi-institutional analysis.
Topics: Aged; Artifacts; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Organometallic Compounds; Respiration | 2020 |
Fabrication of Gd-DOTA-functionalized carboxylated nanodiamonds for selective MR imaging (MRI) of the lymphatic system.
Topics: Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Humans; Lymphatic System; Magnetic Resonance Imaging; Nanodiamonds; Organometallic Compounds | 2021 |
Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Topics: Amino Acids; Animals; Contrast Media; Fibrin; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Molecular Imaging; Neoplasms; Oncogene Proteins; Organometallic Compounds; Peptides; Tumor Microenvironment | 2022 |
Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
Topics: Cerebellar Nuclei; Contrast Media; Gadolinium; Gadolinium DTPA; Globus Pallidus; Humans; Magnetic Phenomena; Magnetic Resonance Imaging; Organometallic Compounds; Retrospective Studies | 2023 |